These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5418158)

  • 41. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.
    Sinclair G; Kerr A
    N Z Med J; 2006 Nov; 119(1245):U2312. PubMed ID: 17146487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Testing at home--the screening of the future?
    de Koning HJ
    Eur J Public Health; 2009 Jan; 19(1):5-6. PubMed ID: 19126573
    [No Abstract]   [Full Text] [Related]  

  • 43. Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes.
    Church TS; LaMonte MJ; Barlow CE; Blair SN
    Arch Intern Med; 2005 Oct; 165(18):2114-20. PubMed ID: 16217001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence fails to support ECG screening for those without heart disease symptoms.
    Mitka M
    JAMA; 2011 Nov; 306(19):2080. PubMed ID: 22089708
    [No Abstract]   [Full Text] [Related]  

  • 45. [Methods in clinical examination with the help of x-ray evaluation of detection of suspected cardiovascular diseases].
    Heublein B; Pocher K; Parsi RA
    Dtsch Gesundheitsw; 1971 Apr; 26(16):722-7. PubMed ID: 5576709
    [No Abstract]   [Full Text] [Related]  

  • 46. Are examination findings important in screening for angina in the Malaysian patient?
    Bulgiba AM
    Prev Med; 2005 Jun; 40(6):696-701. PubMed ID: 15850867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention.
    Reid DD; Brett GZ; Hamilton PJ; Jarrett RJ; Keen H; Rose G
    Lancet; 1974 Mar; 1(7856):469-73. PubMed ID: 4131881
    [No Abstract]   [Full Text] [Related]  

  • 48. Screening for major cardiovascular risk factors among Members of Polish Parliament as a continuation of health marketing for effective cardiovascular prevention in Poland. Warsaw, May 2006.
    Rutkowski M; Zdrojewski T; Bandosz P; Wierucki L; Piwoński J; Piwońska A; Narkiewicz K; Opolski G; Drygas W; Korewicki J; Wyrzykowski B
    Kardiol Pol; 2007 May; 65(5):486-92; discussion 493-4. PubMed ID: 17577845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of dried samples of biological material in screening for hereditary metabolic defects].
    Iakovenko LP; Bialik MA; Krasnopol'skaia KD
    Lab Delo; 1983; (10):16-9. PubMed ID: 6196522
    [No Abstract]   [Full Text] [Related]  

  • 50. [How to differentiate between health and disease in diagnosing the elderly?].
    Jagenburg R; Landahl S; Lindstedt G; Ljunghall S; Nilsson-Ehle H
    Lakartidningen; 1992 Apr; 89(17):1467-73. PubMed ID: 1573934
    [No Abstract]   [Full Text] [Related]  

  • 51. [Tuberculosis screening of patient contacts in 1993 and 1994 in Yaounde, Cameroon].
    Kuaban C; Koulla-Shiro S; Lekama Assiene T; Hagbe P
    Med Trop (Mars); 1996; 56(2):156-8. PubMed ID: 8926876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Automatic ECG diagnosis system (application to mass screening of the circulatory system)].
    Yokoi M; Okamoto N; Mizuno Y; Uozumi Z; Iwatsuka T
    Iyodenshi To Seitai Kogaku; 1973 Jun; 11(3):195-206. PubMed ID: 4588781
    [No Abstract]   [Full Text] [Related]  

  • 53. [Evaluation of the circulatory system in workers in the cellulose-paper industry].
    Sinkiewicz W; Dziedziczko A; Hoffmann A
    Med Pr; 1998; 49(2):147-56. PubMed ID: 9695062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
    Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
    Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Second and subsequent periodic examinations.
    Harnes JR
    N Y State J Med; 1976 Jun; 76(6):891-97. PubMed ID: 1064762
    [No Abstract]   [Full Text] [Related]  

  • 56. [CBO guidelines on diagnosis, treatment, and prevention of complication in diabetes mellitus: retinopathy, foot ulcers, nephropathy and cardiovascular diseases. Dutch Institute for Quality Assurance].
    van Ballegooie E; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):413-8. PubMed ID: 10719544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Measurement of protein loss in the urine. A useful addition in cardiovascular disease risk assessment].
    Stehouwer CD; Gansevoort RT
    Ned Tijdschr Geneeskd; 2009 Apr; 153(17):796. PubMed ID: 19469210
    [No Abstract]   [Full Text] [Related]  

  • 58. The detection of individuals prone to coronary artery disease--a screening program conducted on medical students.
    Berenson GS; Srinivasan SR; Pargaonkar PS; Lindsey S; Plavidal F; Radhakrishnamurthy B; Dalferes ER; Lopez A; Dugan FA
    J La State Med Soc; 1971 Feb; 123(2):49-56. PubMed ID: 5573242
    [No Abstract]   [Full Text] [Related]  

  • 59. [Screening - the basis for planning of specialized services].
    Vrábelová R
    Cesk Zdrav; 1979 Sep; 27(8-9):327-34. PubMed ID: 487486
    [No Abstract]   [Full Text] [Related]  

  • 60. Commentary: Screening: a seductive paradigm that has generally failed us.
    Gøtzsche PC
    Int J Epidemiol; 2015 Feb; 44(1):278-80. PubMed ID: 25596213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.